Same Day Pancreatic Cancer & Tumour Marker Blood Test (Walk-In) – £110

A Story of Death: A Pancreatic Blood Test
About a Disastrous Diagnosis

I discovered that I had cancer at the age of 31 through a CA19 test, which is a pancreatic cancer tumor. I will continue to share with you the accounts of individuals who have encountered traumatic diagnoses and discuss their experiences. “My ovaries are adorned with substantial cysts, as indicated by an ultrasound.” My condition continued to deteriorate, despite the fact that I underwent ultrasounds every two weeks to monitor them. I experienced significant weight loss, which exacerbated my concerns regarding my infant’s health.

“On October 18, I underwent another routine ultrasound.”

My obstetrician-gynecologist inquired about my emotional state, and I informed her that I am not eating much and that the child is not moving much, which is causing me distress. The doctor’s decision was unexpected; she claimed that I was not receiving an adequate amount of nutrients, and as a result, I was transferred to the CA19 hospital to address this matter.

He was fortunate to be in good health; however, his lungs required further development. Things were not going well for me; I was in intensive care due to the necessity of removing fluid from my abdomen and lungs.

No one was able to provide me with an explanation as to its origin.

My OB/GYN visited me a few hours after I gave birth to inform me that my ovaries appeared “extremely livid.” She recommended that I undergo a pancreatic blood test and subsequently undergo a hysterectomy to eliminate them. My son and I were permitted to return home after a period of time. We were eventually reunited as a family of four, and I was confident that all the negative events were behind us. My OB/GYN was notified, and I was subsequently scheduled for an additional ultrasound of my left arm.

The examination revealed that I had a clot.

I was back in the hospital, where I underwent an endoscopy and a colonoscopy. The results of both procedures were unremarkable. Then, as the blood clot was dissolving, I inquired with the physician whether my CA19 symptoms could serve as warning signs.

The physician indicated that, in general, the answer is affirmative; however, he recommended that we await the results. “On November 5, we discovered that I have stage 4 pancreatic disease.”

Metastatic pancreatic cancer was detected through a biopsy of my ovaries.

My “evil” ovaries during pregnancy were a result of the cancer’s progression from my pancreas to my ovaries. Subsequently, a CT scan revealed lesions on my pancreas, which, when combined with the biopsy results, verified my diagnosis.

Afterward, I endeavored to reconcile myself to the hard reality.

Our daughter was five years old, and our son was less than one month old. We were the quintessential small family. Will I be able to see my infant at six months? Will I have the opportunity to observe my daughter attend kindergarten? What about education? Nobody was capable of responding to my inquiries. “I was informed that I would never undergo surgery to remove the tumor due to its metastasis and its expansion into significant arteries.”

I was nevertheless encouraged by my oncologist. A few weeks following my diagnosis, I initiated chemotherapy. I was most apprehensive about the possibility that the doctor would inform me that I had only six months to live. However, he refrained from doing so. Although I was prepared to combat this illness, I also desired to ensure that my two young children’s lives were as consistent as feasible.

The Pancreatic CA19 Blood Test report was followed by months of CA-19 treatment, which were challenging due to the way chemotherapy disrupts one’s routine. However, on the occasions when circumstances were not as adverse, we endeavored to engage in a unique family activity. My father, sibling, other family members, and friends were my greatest advocates, in addition to my mother and husband.

They brought me food, sat with me, and allowed me to weep.

They persisted in asserting, “We will prevail,” and they consistently demonstrated their presence during challenging periods. It held significant value for me. Despite the fact that the chemotherapy was effective, it exacerbated the challenges I faced as a mother. When it came to my offspring, I had restricted choices. Throughout the four to five days following my chemotherapy treatment, I was confined to my bed due to the severe discomfort I experienced. My children would visit me or join me in watching television.

After examining the CA19 blood testing history and observing the efficacy of chemotherapy, a specialist recommended that I consult with a colleague who is renowned for his surgical expertise. The surgeon informed me that he believed he could perform surgery during this travel in December 2012.

However, prior to the operation, he desired to undergo radiation therapy to the ilium and pancreas.

The radiation was administered in February 2013, and the tumor was surgically removed the following month. We accompanied our children to this operation. We were transparent with them regarding my cancer diagnosis from the outset. And now, after such a long period, they hold dear every moment they spend with their father and me.

We frequently navigate our metropolis by automobile. We enjoy spending time together and endeavor to engage in as many activities as feasible. Following my surgery, I underwent chemotherapy and underwent examinations every three months. A spot on my left lung was identified by CA19 physicians in 2014, and a biopsy was conducted. It was a metastasis.

In July of that year,

I was required to undergo surgery to remove a portion of my left lung. In May 2014, I began experiencing seizures. I was unaware of the situation, and my physicians were as well; they believed that it was merely back muscle contractions. However, the episodes continued to deteriorate. A tumor was discovered on the left side of my brain during the examination. In November of that year, I was referred to a distinguished neurosurgeon who successfully removed the tumor. The CA-19 pancreatic cancer assays indicated that the biopsy specimen contained metastases.

I was subjected to brain radiation for a week in order to eradicate any remaining disease cells. And everything was normal until, three years later, in 2016, it reappeared. I received radiation treatment once more, and for a period of time, there were no indications of progression.

However, in May 2017, I experienced an attack.

The radiation oncologist conducted an MRI and observed brain inflammation. Upon my return home, they administered steroids and advised me that if the inflammation did not subside, it could be indicative of a more severe condition, such as metastases.

Steroids were ineffective, and I subsequently resumed chemotherapy.

In terms of the entire experience, I would argue that the most difficult and detrimental aspect was the impact on the intellect. I was unable to think coherently. Even the nerve was affected by the surgery to remove the metastases, resulting in my foot dropping and my leg being unable to be lifted in a normal manner.

I was unable to participate in certain activities with my children due to the physical limitations imposed by brain surgery and multiple radiation treatments.

I am fortunate to have companions who are able to provide assistance.

I was unable to transport my children to a certain location, so my pals stepped in. Furthermore, my children comprehend full well that I am incapable of accomplishing everything that other mothers are capable of. I underwent chemotherapy until January 2020, at which point my oncologists informed me of an immunotherapy treatment that had been evaluated on patients with the same genetic mutation as I.

The physicians inquired whether it would be effective for me, as these patients responded favorably to it. Certainly, it was. I undergo a CT scan of my thorax, abdomen, and pelvis every three months. I undergo an MRI of my brain every four months. Since that time, my scans have been clean, and I have not experienced any symptoms of illness.

Additionally, there are no adverse effects associated with the treatment.

I have been afflicted with pancreatic disease for 11 years, and I am currently 41 years old. I am aware that I am an uncommon exception. I am appreciative of the assistance I received from my CA-19 Cancer treatment in overcoming these challenges. The targeted chemotherapy that enabled me to undergo surgery and radiation, as well as the immunotherapy I initiated last year, were made feasible by the efforts of my physicians.